Bavarian Nordic Provides 2016 Update

November 12, 2016

Bavarian Nordic, a biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases, this week announced interim financial results for the first three quarters of [Read more]

Biodefense Headlines – August 28, 2016

August 28, 2016

See what we’re reading this week at Global Biodefense on topics including an anthrax outbreak simulation, Ebola virus disease small molecule countermeasures, and bioterrorism threats to the water supply. BIOPREPAREDNESS UN Chief warns world [Read more]

SIGA Gets Greenlight on Smallpox Drug Phase 3 Trial

February 24, 2016

SIGA Technologies, Inc. today announced the receipt of FDA concurrence on a dose for continuing the pivotal clinical human safety study for tecovirimat, an antiviral pharmaceutical to treat orthopoxvirus-related diseases, including smallpox. [Read more]

Biodefense Headlines – Dec 27, 2015

December 27, 2015

See what we’re reading this week at Global Biodefense on topics including bioterrorism in the modern age, hospital mass casualty preparedness, and communications during an epidemic. BIODEFENSE POLICY & PRACTICES The revolving door of [Read more]

Biodefense Headlines – Dec 6, 2015

December 6, 2015

See what we’re reading this week at Global Biodefense on topics including the ethics of quarantines, rapid spread of Zika virus, anthrax post-exposure vaccine approval, biosafety accountability and more… BIODEFENSE POLICY & [Read more]

1 2 3 4 6